Cargando…
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors
BACKGROUND: Carcinoid heart disease, a known complication of neuroendocrine tumors, is characterized by right heart fibrotic lesions. Carcinoid heart disease has traditionally been defined by the degree of valvular involvement. Right ventricular (RV) dysfunction due to mural involvement may also be...
Autores principales: | Bergestuen, Deidi Strickland, Gravning, Jørgen, Haugaa, Kristina Hermann, Sahakyan, Laura G, Aakhus, Svend, Thiis-Evensen, Espen, Øie, Erik, Aukrust, Pål, Attramadal, Håvard, Edvardsen, Thor |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087327/ https://www.ncbi.nlm.nih.gov/pubmed/20053285 http://dx.doi.org/10.1186/1471-2407-10-6 |
Ejemplares similares
-
Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
por: Gedde-Dahl, Merete, et al.
Publicado: (2013) -
Myocardial Connective Tissue Growth Factor (CCN2/CTGF) Attenuates Left Ventricular Remodeling after Myocardial Infarction
por: Gravning, Jørgen, et al.
Publicado: (2012) -
Structural insights into regulation of CCN protein activities and functions
por: Monsen, Vivi Talstad, et al.
Publicado: (2023) -
CTGF/CCN2 Postconditioning Increases Tolerance of Murine Hearts towards Ischemia-Reperfusion Injury
por: Kaasbøll, Ole Jørgen, et al.
Publicado: (2016) -
The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2
por: Zolfaghari, Sima, et al.
Publicado: (2022)